ObesityFABNCT04577547
Food, Activity and Behavior Study
A study testing DGA diet WL & exercise, DGA diet WL & no exercise and DGA diet WM & exercise in people with Obesity, run by USDA Grand Forks Human Nutrition Research Center.
Trial summary
The purpose of this research is to test the effects of the Dietary and Physical Activity Guidelines for Americans on health and on eating and exercise behaviors. Read more about this study
- Who is it for?
- Ages 18 to 65 yearsHealthy volunteers can take part
- Conditions the study is for
- Obesity
- What is being tested?
- DGA diet WL & exercise, DGA diet WL & no exercise and DGA diet WM & exercise
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 0 participants
- Where
- No sites listed yet
- Study dates
- Oct 2024to Dec 2029
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Obese (BMI 30.0 kg/m2 - 350 lbs [maximum weight for dual energy x-ray absorptiometry (DXA) machine])
- No contraindications to participate in exercise
- hs-CRP level ≥3.0 and ≤10.0 mg/L or two consecutive measures of >10.0 mg/L measured two weeks apart
- Access to high-speed internet
Who cannot join
- Taking chronic anti-inflammatory medications
- Being pregnant, lactating, or planning to become pregnant
- Diagnosed eating disorder
- Taking weight loss medication
- Smoking
- Overt hypothyroidism
Show all 13Show fewer
- Cancer
- Physical conditions that prevent safe exercise
- Liking of <3 out of 10 for all available physical activity modes
- Currently exercising for more than 30 minutes per day >3 days per week
- Unwilling to continue with current exercise routine
- Not willing to comply with all study requirements
- Blood pressure greater than 140/90
About this study
Official title: Efficacy of the Dietary Guidelines for Americans and the Physical Activity Guidelines for Americans for Weight Control
The purpose of this research is to test the effects of the Dietary and Physical Activity Guidelines for Americans on health and on eating and exercise behaviors.
Read the detailed description
The Dietary Guidelines for Americans (DGA), which include the Physical Activity Guidelines for Americans (PAGA), is the primary United States (U.S) government resource for weight control. The researchers propose that chronic, low grade inflammation (CLGI) limits weight control by acting upon physiological and behavioral factors that moderate weight control. Diet and exercise reduce CLGI and provide weight control, but no one has investigated the efficacy of the DGA and PAGA to reduce CLGI, whether reduced CLGI promotes greater weight control, and the moderating roles of physiological and behavioral factors on the association of reduced CLGI with weight control. To accomplish this, the researchers will conduct a 6-month trial in 224 obese adults; a 3-month controlled feeding trial with four dietary arms; 1) DGA with weight loss, 2) Western diet with weight loss,3) DGA diet weight maintenance, 4) Western diet weight maintenance. Each dietary arm will have PAGA-recommended exercise and non-exercise arms. Post-trial is a 3-month weight maintenance period. The primary outcome is change in C-reactive protein (CRP), a marker of CLGI. The results will inform the DGA and PAGA; thereby helping clinicians, public health workers, and policymakers to improve the health of Americans.
- Conditions
- Obesity
- Being tested
- DGA diet WL & exercise, DGA diet WL & no exercise, DGA diet WM & exercise, DGA diet WM & no exercise, Western diet WL & exercise
- Medical subject headings
- Obesity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
DGA diet WL & exerciseOther
Intake of DGA weight loss 8 day rotating menu \& PAGA-recommended exercise
DGA diet WL & no exerciseOther
Intake of DGA weight loss 8 day rotating menu \& no exercise
DGA diet WM & exerciseOther
Intake of DGA weight maintenance 8 day rotating menu \& PAGA-recommended exercise
DGA diet WM & no exerciseOther
Intake of DGA weight maintenance 8 day rotating menu \& no exercise
Western diet WL & exerciseOther
Intake of Western-type weight loss 8 day rotating menu \& PAGA-recommended exercise
Western diet WL & no exerciseOther
Intake of Western-type weight loss 8 day rotating menu \& no exercise
Western diet WM & exerciseOther
Intake of Western-type weight maintenance 8 day rotating menu \& PAGA-recommended exercise
Western diet WM & no exerciseOther
Intake of Western-type weight maintenance 8 day rotating menu \& no exercise
| Study group | Role | What they receive |
|---|---|---|
| Dietary Guidelines (DGA) diet with weight loss (WL) & exercise | Experimental | Menu to provide DGA-recommended food group amounts at a calorie level to promote weight loss with Physical Activity Guidelines for Americans (PAGA)-recommended exercise Receives: Other: DGA diet WL & exercise |
| DGA diet with WL & no exercise | Experimental | Menu to provide DGA-recommended food group amounts at a calorie level to promote weight loss with no exercise Receives: Other: DGA diet WL & no exercise |
| DGA diet weight maintenance (WM) & exercise | Experimental | Menu to provide DGA-recommended food group amounts at a calorie level to promote weight maintenance with PAGA-recommended exercise Receives: Other: DGA diet WM & exercise |
| DGA diet WM & no exercise | Experimental | Menu to provide DGA-recommended food group amounts at a calorie level to promote weight maintenance with no exercise Receives: Other: DGA diet WM & no exercise |
| Western diet with WL & exercise | Experimental | Western-type menu to provide a calorie level to promote weight loss with PAGA-recommended exercise Receives: Other: Western diet WL & exercise |
| Western diet with WL & no exercise | Experimental | Western-type menu to provide a calorie level to promote weight loss with no exercise Receives: Other: Western diet WL & no exercise |
| Western diet WM exercise | Experimental | Western-type menu to provide a calorie level to promote weight maintenance with PAGA-recommended exercise Receives: Other: Western diet WM & exercise |
| Western diet WM no exercise | Experimental | Western-type menu to provide a calorie level to promote weight maintenance with no exercise Receives: Other: Western diet WM & no exercise |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in C-reactive protein (CRP)
The effect of diet and exercise on CRP
Measured: Weeks 0, 2, 4, 6, 8, 10, 12, 24
Relative reinforcing value (RRV) of energy-dense snack foods
The effect of consuming a healthy DGA style or a Western style diet during weight loss and weight maintenance on the RRV of energy-dense snack food using a computer choice paradigm. For the computer choice paradigm subjects click the mouse button to play a simulated slot machine games to earn points toward receiving a portion of food or being able to do a non-food related sedentary activity (e.g., watching TV).
Measured: Weeks 0,12, 24
Relative reinforcing value (RRV) of exercise
The effect of achieving the DGA recommended amounts of exercise during weight loss and weight maintenance on relative reinforcing value of exercise compared to a sedentary activity alternative using a computer choice paradigm. For the computer choice paradigm subjects click the mouse button to play a simulated slot machine games to earn points toward being able to do a chosen physical activity, such as walking on a treadmill, or a sedentary activity (e.g., watching TV).
Measured: Weeks 0,12, 24
Fat and carbohydrate oxidation
The effect of diet and exercise on carbohydrate and fat oxidation in response to meals and exercise as measured by whole-room calorimetry
Measured: Weeks 0,12
Secondary outcomes (12)
Food Cognitive Interference
The effect of diet and exercise on food cognitive interference, one of the three cognitive domains of executive function, using a computerized Food Stroop test.
Measured: Weeks 0, 12, 24
Cognitive flexibility
The effect of diet and exercise on cognitive flexibility, one of the three cognitive domains of executive function, using a computerized Trail-Making test B/A.
Measured: Weeks 0, 12, 24
Working memory
The effect of diet and exercise on cognitive flexibility, one of the three cognitive domains of executive function, using the Wisconsin Card Sorting Task.
Measured: Weeks 0, 12, 24
Inflammation
The effect of diet and exercise on plasma pro-inflammatory cytokines (e.g., Il-6, MCP-1, TNF-alpha) and anti-inflammatory cytokines (e.g., IL-10, Soluble TNF receptor I and II)
Measured: Weeks 0, 2, 4, 6, 8, 10, 12, 24
Change in adipokines
The effect of diet and exercise on plasma adipokines (e.g., adiponectin, resistin)
Measured: Weeks 0, 2, 4, 6, 8, 10, 12, 24
Change in myokines
The effect of diet and exercise on plasma myokines (e.g., BDNF, Myostatin, FGF-21, Irisin)
Measured: Weeks 0, 2, 4, 6, 8, 10, 12, 24
Change in bile acids
The effect of diet and exercise on plasma bile acids (i.e., glycocholic acid, glyco-CDCA, glyco-HDCA, hyocholic acid, hyodeoxycholic acid)
Measured: Weeks 0, 2, 4, 6, 8, 10, 12, 24
Change in blood lipids
The effect of diet and exercise on cholesterol, HDL, triglycerides
Measured: Weeks 0, 2, 4, 6, 8, 10, 12, 24
Change in weight control moderators
Questionnaires (i.e., three-factor eating questionnaire, reward base eating, food attitudes and behavior survey) that when scored provide a single number will be used to determine the moderating effect of self efficacy, restraint and disinhibition maintaining diet and exercise changes
Measured: Weeks 0,12, 24
Change in humoral biomarkers of eating behavior
The effect of diet and exercise on ghrelin, leptin, thyroid hormones, gut peptides, fatty acids
Measured: Weeks 0, 2, 4, 6, 8, 10, 12, 24
Gene expression profiles of glucose oxidation
The effect of diet and exercise on gene expression profiles associated with glucose oxidation (i.e., hexokinase, phosphofructokinase, pyruvate dehydrogenase kinase 4, peroxisome proliferator-activated receptor alpha gene expression)
Measured: Weeks 0, 2, 4, 6, 8, 10, 12, 24
Gene expression profiles of fat oxidation
The effect of diet and exercise on on gene expression profiles associated with fat oxidation (i.e., fatty acid translocase, fatty acid synthase, acetyl Co-A carboxylase 2, stearoyl Co-A desaturase gene expression)
Measured: Weeks 0, 2, 4, 6, 8, 10, 12, 24
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Oct 2020
- Study startOct 2024 (estimated)
- Primary completionDec 2029 (estimated)
- Study completionDec 2029 (estimated)
Why it stopped: Never started
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for ObesityStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Factorial
- Masking
- None (open label)
- Enrolment
- 0 participants (actual)
Sponsor and investigators
- Lead sponsor
- USDA Grand Forks Human Nutrition Research Center
- Sponsor type
- US federal agency
- Responsible party
- Sponsor
- Investigators
- Shanon Casperson, PhD, Principal investigator, USDA Grand Forks Human Nutrition Research CenterJames Roemmich, PhD, Principal investigator, USDA Grand Forks Human Nutrition Research Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04577547
- Sponsor's protocol ID
- GFHNRC512
- Acronym
- FAB
- Status last verified
- Jan 2023
- First submitted
- 18 Jun 2020
- Last updated
- 11 Jan 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 11 Jan 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Efficacy of the Dietary Guidelines for Americans and the Physical Activity Guidelines for Americans for Weight Control
- ClinicalTrials.gov ID
- NCT04577547
- Acronym / sponsor ID
- FAB / GFHNRC512
- Conditions
- Obesity
- Study type
- Interventional
- Recruitment status
- WithdrawnReason stopped: Never started
- Enrolment
- 0 participants (actual)
- Lead sponsor
- USDA Grand Forks Human Nutrition Research CenterUS federal agency
- Study start
- Oct 2024 (estimated)
- Primary completion
- Dec 2029 (estimated)
- Study completion
- Dec 2029 (estimated)
- First posted
- 8 Oct 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this research is to test the effects of the Dietary and Physical Activity Guidelines for Americans on health and on eating and exercise behaviors.
Detailed description
The Dietary Guidelines for Americans (DGA), which include the Physical Activity Guidelines for Americans (PAGA), is the primary United States (U.S) government resource for weight control. The researchers propose that chronic, low grade inflammation (CLGI) limits weight control by acting upon physiological and behavioral factors that moderate weight control. Diet and exercise reduce CLGI and provide weight control, but no one has investigated the efficacy of the DGA and PAGA to reduce CLGI, whether reduced CLGI promotes greater weight control, and the moderating roles of physiological and behavioral factors on the association of reduced CLGI with weight control. To accomplish this, the researchers will conduct a 6-month trial in 224 obese adults; a 3-month controlled feeding trial with four dietary arms; 1) DGA with weight loss, 2) Western diet with weight loss,3) DGA diet weight maintenance, 4) Western diet weight maintenance. Each dietary arm will have PAGA-recommended exercise and non-exercise arms. Post-trial is a 3-month weight maintenance period. The primary outcome is change in C-reactive protein (CRP), a marker of CLGI. The results will inform the DGA and PAGA; thereby helping clinicians, public health workers, and policymakers to improve the health of Americans.
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Factorial
- Masking
- None (open label)
- Number of arms
- 8
| Arm | Type | Receives |
|---|---|---|
| Dietary Guidelines (DGA) diet with weight loss (WL) & exercise | Experimental | Other: DGA diet WL & exerciseMenu to provide DGA-recommended food group amounts at a calorie level to promote weight loss with Physical Activity Guidelines for Americans (PAGA)-recommended exercise |
| DGA diet with WL & no exercise | Experimental | Other: DGA diet WL & no exerciseMenu to provide DGA-recommended food group amounts at a calorie level to promote weight loss with no exercise |
| DGA diet weight maintenance (WM) & exercise | Experimental | Other: DGA diet WM & exerciseMenu to provide DGA-recommended food group amounts at a calorie level to promote weight maintenance with PAGA-recommended exercise |
| DGA diet WM & no exercise | Experimental | Other: DGA diet WM & no exerciseMenu to provide DGA-recommended food group amounts at a calorie level to promote weight maintenance with no exercise |
| Western diet with WL & exercise | Experimental | Other: Western diet WL & exerciseWestern-type menu to provide a calorie level to promote weight loss with PAGA-recommended exercise |
| Western diet with WL & no exercise | Experimental | Other: Western diet WL & no exerciseWestern-type menu to provide a calorie level to promote weight loss with no exercise |
| Western diet WM exercise | Experimental | Other: Western diet WM & exerciseWestern-type menu to provide a calorie level to promote weight maintenance with PAGA-recommended exercise |
| Western diet WM no exercise | Experimental | Other: Western diet WM & no exerciseWestern-type menu to provide a calorie level to promote weight maintenance with no exercise |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Obese (BMI 30.0 kg/m2 - 350 lbs [maximum weight for dual energy x-ray absorptiometry (DXA) machine])
- No contraindications to participate in exercise
- hs-CRP level ≥3.0 and ≤10.0 mg/L or two consecutive measures of >10.0 mg/L measured two weeks apart
- Access to high-speed internet
Key exclusion criteria (13 listed)
- Taking chronic anti-inflammatory medications
- Being pregnant, lactating, or planning to become pregnant
- Diagnosed eating disorder
- Taking weight loss medication
- Smoking
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| DGA diet WL & exerciseIntake of DGA weight loss 8 day rotating menu \& PAGA-recommended exercise | Other | Dietary Guidelines (DGA) diet with weight loss (WL) & exercise |
| DGA diet WL & no exerciseIntake of DGA weight loss 8 day rotating menu \& no exercise | Other | DGA diet with WL & no exercise |
| DGA diet WM & exerciseIntake of DGA weight maintenance 8 day rotating menu \& PAGA-recommended exercise | Other | DGA diet weight maintenance (WM) & exercise |
| DGA diet WM & no exerciseIntake of DGA weight maintenance 8 day rotating menu \& no exercise | Other | DGA diet WM & no exercise |
| Western diet WL & exerciseIntake of Western-type weight loss 8 day rotating menu \& PAGA-recommended exercise | Other | Western diet with WL & exercise |
| Western diet WL & no exerciseIntake of Western-type weight loss 8 day rotating menu \& no exercise | Other | Western diet with WL & no exercise |
| Western diet WM & exerciseIntake of Western-type weight maintenance 8 day rotating menu \& PAGA-recommended exercise | Other | Western diet WM exercise |
| Western diet WM & no exerciseIntake of Western-type weight maintenance 8 day rotating menu \& no exercise | Other | Western diet WM no exercise |
Primary outcome
Change in C-reactive protein (CRP)
Time frame: Weeks 0, 2, 4, 6, 8, 10, 12, 24
The effect of diet and exercise on CRP
Relative reinforcing value (RRV) of energy-dense snack foods
Time frame: Weeks 0,12, 24
The effect of consuming a healthy DGA style or a Western style diet during weight loss and weight maintenance on the RRV of energy-dense snack food using a computer choice paradigm. For the computer choice paradigm subjects click the mouse button to play a simulated slot machine games to earn points toward receiving a portion of food or being able to do a non-food related sedentary activity (e.g., watching TV).
Relative reinforcing value (RRV) of exercise
Time frame: Weeks 0,12, 24
The effect of achieving the DGA recommended amounts of exercise during weight loss and weight maintenance on relative reinforcing value of exercise compared to a sedentary activity alternative using a computer choice paradigm. For the computer choice paradigm subjects click the mouse button to play a simulated slot machine games to earn points toward being able to do a chosen physical activity, such as walking on a treadmill, or a sedentary activity (e.g., watching TV).
Fat and carbohydrate oxidation
Time frame: Weeks 0,12
The effect of diet and exercise on carbohydrate and fat oxidation in response to meals and exercise as measured by whole-room calorimetry
12 secondary outcomes
Food Cognitive Interference
Time frame: Weeks 0, 12, 24
Cognitive flexibility
Time frame: Weeks 0, 12, 24
Working memory
Time frame: Weeks 0, 12, 24
Inflammation
Time frame: Weeks 0, 2, 4, 6, 8, 10, 12, 24
Change in adipokines
Time frame: Weeks 0, 2, 4, 6, 8, 10, 12, 24
Change in myokines
Time frame: Weeks 0, 2, 4, 6, 8, 10, 12, 24
Change in bile acids
Time frame: Weeks 0, 2, 4, 6, 8, 10, 12, 24
Change in blood lipids
Time frame: Weeks 0, 2, 4, 6, 8, 10, 12, 24
Change in weight control moderators
Time frame: Weeks 0,12, 24
Change in humoral biomarkers of eating behavior
Time frame: Weeks 0, 2, 4, 6, 8, 10, 12, 24
Gene expression profiles of glucose oxidation
Time frame: Weeks 0, 2, 4, 6, 8, 10, 12, 24
Gene expression profiles of fat oxidation
Time frame: Weeks 0, 2, 4, 6, 8, 10, 12, 24
Results and safety
The study was withdrawn before enrolling participants, so there are no results.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 11 Jan 2023.
- Grand Forks Human Nutrition Research Center Current Nutrition StudiesLink provided by the sponsor.
- Individual participant dataSharing planned: No
Related trials for Obesity
Not yet recruitingPhase 2
Trial of the Combination of Alpha-Lipoic Acid and Mirabegron in Women and in Men With Obesity
Insulin Resistance, Obesity
Not yet recruiting
Puerto Rican Obesity Intervention for Men
Obesity
Enrolling by invitation
Impact of a Playful Family Education Strategy With ICT on Childhood Obesity Prevention
Pediatric Obesity, Childhood Obesity
Not yet recruitingObservational study
Assessing the Impact of Perceptions of Unpredictability on Objective Measures of Food Consumption and Metabolism
Healthy Volunteer, Obestity
Active, not recruitingPhase 1/2
A First-In-Human Study of ARO-INHBE in Adults With Obesity With and Without Type 2 Diabetes Mellitus
Obesity
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Shanon Casperson, PhD principal investigator
USDA Grand Forks Human Nutrition Research Center
James Roemmich, PhD principal investigator
USDA Grand Forks Human Nutrition Research Center
Questions about this trial
What is this clinical trial studying?
A study testing DGA diet WL & exercise, DGA diet WL & no exercise and DGA diet WM & exercise in people with Obesity, run by USDA Grand Forks Human Nutrition Research Center.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: withdrawn, as of the sponsor's last update on 11 Jan 2023. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study was withdrawn before enrolling participants, so there are no results.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in C-reactive protein (CRP) (time frame: Weeks 0, 2, 4, 6, 8, 10, 12, 24). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Jan 2023; AzTrials last refreshed its copy on 1 Nov 2026.